Awards and Announcements (August 2015)
Amanda Graf, MD, FAAP, Receives FAME Career Development Award for Clinicians
Mark W. Hall, MD, Receives Development Board Endowed Chair in Critical Care Medicine
Hadoop Cluster Drives Better Pediatric Care Through Big Data Analytics, First of Its Kind in Ohio
Maranda McKinley Receives Quarterly Employee Recognition Award
Recent Grants Awarded to Investigators in The Research Institute
DNABII Proteins Play Critical Role in Maintaining Biofilm Structure of Uropathogenic E. coli, a Major Cause of UTIs
Steven D. Goodman, PhD, principal investigator in the Center for Microbial Pathogenesis at The Research Institute at Nationwide Children’s, is lead author of a Molecular Microbiology study that demonstrates the importance of DNABII proteins for the development of biofilms, microbial communities involved in most chronic and recurrent bacterial infections, including urinary tract infections.
Biomarkers Identify Risk of Thrombosis, a Serious Complication of Nephrotic Syndrome
Bryce Kerlin, MD, principal investigator in the Center for Clinical and Translational Research at The Research Institute and a hematologist specializing in blood clotting disorders at Nationwide Children’s, is lead author on a Journal of the American Society of Nephrologists study that suggests protein in the urine and/or blood levels of albumin could be developed as clinically meaningful surrogate biomarkers of excessive blood clotting.
Virotherapy Shows Promise Against Highly Malignant Pediatric Tumors
Adam Studebaker, PhD, research scientist in the Center for Childhood Cancer and Blood Diseases at The Research Institute at Nationwide Children’s, is lead author of a recent Neuro-Oncology paper that shows a modified measles virus is an effective therapeutic agent against a type of tumor that does not respond well to chemotherapy and primarily affects children under 3 years of age
Contact Research Now